An engaged, motivated audience
People who have chosen to understand and manage their own health — in categories from pets to maternal care to chronic conditions — already using a 24/7 companion that knows their whole story.
StoryMD's three journey tiers map to eight company-scale verticals, each a market a pharmaceutical company, payer, provider or investor can power, sponsor or acquire today. The traditional world builds a separate app for each. StoryMD runs them all on one longitudinal record, already built, deployed and live on iOS.
Every vertical below is traditionally served by its own app, portal or point solution. StoryMD unifies medical records, labs, wearables, biomarkers and personal goals into one AI-driven story, then serves every market from it.
The three tiers follow a person's life: everyday wellbeing, protecting the years ahead, and facing a diagnosis. The same record stays with them throughout.
People actively investing in their health, family and performance.
Proactive people protecting the years ahead.
People facing a serious or chronic diagnosis.
Each market served from the same record
The common platform
The same engine powers every vertical above, so a new market is a new audience, not a new build.
Every vertical is built and live today: a company-scale market a partner can adopt as a platform, sponsor, or acquire to serve its audience.
A $150B market with no system of record, and StoryMD built the first one.
Pet health is the largest consumer-health category with no FHIR-native record. StoryMD Pets is built and live, giving every animal the lifelong health record it has never had, explained by an AI companion that knows the whole story.
What a partner gets
The first FHIR-native pet health record and a direct relationship with deeply engaged owners, in the largest consumer-health category with no system of record and no incumbent.
The fastest-growing drug class in a generation, and most people quit within a year.
GLP-1s don't fail on efficacy; they fail on persistence, with 50–75% of people off therapy within twelve months. StoryMD connects labs, wearables and symptoms into one evolving story, tracking the signals that predict drop-off and giving people the guidance to stay on.
What a partner gets
A guided journey that helps people stay on therapy through the signals that predict drop-off, in the largest category in medicine, where persistence, not efficacy, is the whole game.
One relationship from IVF to a child's fifth birthday, where the market sees three apps.
A mother is handed off at every stage: a fertility app, then a pregnancy app, then a baby app, losing the thread each time. StoryMD keeps one longitudinal record across all of it, carried by a proprietary conception-to-birth library forty years in the making.
What a partner gets
An unbroken relationship across fertility, pregnancy and early childhood, carried by 40 years of proprietary conception-to-birth scientific visualizations no single-stage app can match.
Every wearable measures. No brand owns the interpretation yet.
Wearables made metrics abundant; the next shift is meaning. StoryMD unifies clinical, genetic and wearable data into one evolving model of human adaptation, the layer that endures as hardware commoditizes and metrics multiply.
What a partner gets
The longitudinal layer that turns continuous signals into a living model of adaptation: the interpretation layer no wearable brand owns yet.
The highest-retention audience on the platform, and two markets at once.
Families caring for a child with a rare or chronic condition, and adults caring for an aging parent, live the same chaos. StoryMD gives both one clear, shared record that families, caregivers and clinicians can follow together.
What a partner gets
The highest-retention audience on the platform, and one shared record for families, caregivers and the organizations that support them, in pediatric and senior care at once.
The prevention economy, built on biomarkers read in context.
Nine in ten cases of type 2 diabetes may be preventable, and healthy habits add 8–13 years of life, but only when risk is understood, read together and followed over time. StoryMD closes that gap, so risk is caught while it's still reversible.
What a partner gets
More than 1,000 biomarkers read in context and followed over time: the longitudinal record that turns a one-time panel into an ongoing understanding of how someone is really aging.
The first standards-coded library of human emotion: how you feel, in the record.
StoryMD put more than 130 emotional states into the medical record, coded to MeSH and carried as FHIR Observations, so how someone feels is tracked over time and read beside their labs, medications and diagnoses, not siloed in a separate wellness app.
What a partner gets
How someone feels, tracked continuously and read beside the rest of their record, something no episodic questionnaire or closed wellness app can offer.
The core clinical market: every serious and chronic diagnosis, mapped to the record.
A coded, visual knowledge base of more than 6,000 conditions, mapped to each patient's own labs and medications, with a 24/7 companion that helps them understand, track, manage and improve: a breadth and depth no single-disease app can match.
What a partner gets
An AI-guided journey for more than 6,000 conditions, mapped to the patient's own record: a breadth across every specialty that no single-disease app can match, on one FHIR-native platform.
StoryMD is already built, deployed and live on iOS — $68M invested in the platform underneath all eight verticals. A partner doesn't fund a build; they reach an engaged audience through a product that already works.
People who have chosen to understand and manage their own health — in categories from pets to maternal care to chronic conditions — already using a 24/7 companion that knows their whole story.
Partners can support condition and wellness programs that put people in control of their own data. Everything is consent-based and patient-governed first — the person owns their health story, and chooses what they share.
People don't stay in one tier. They optimize, they worry, they're diagnosed, they recover, moving in both directions for life. StoryMD keeps the relationship at every step, so nothing a person has learned is lost at the next transition.
High-intent life stages: pets, maternal care, GLP-1, caregiving and performance, people already investing in their health.
Optimization and prevention: longevity, screening and mental wellbeing, catching risk while it's still reversible.
Diagnosis and chronic care: oncology, cardiometabolic, complex and rare conditions, the deepest and most sustained engagement.
No incumbent combines breadth across every condition, a longitudinal FHIR-native record, movement across all three tiers, and a 24/7 companion mapped to the person's own record. Point solutions win one cell; StoryMD wins the row. And four shifts are opening the window at once.
FHIR is now the standard for health data, so for the first time a longitudinal record can move across systems.
A generational adherence problem, with 50–75% stopping within a year, needs exactly the longitudinal journey StoryMD provides.
Making thousands of conditions personal, visual and conversational is finally possible at scale.
Healthcare is moving to understand how people actually do over time, and a consented, patient-governed longitudinal record is how that understanding is built.
Each vertical proves the same thing again: one longitudinal record, an engaged audience, and a breadth no point solution can match, already built and live. A partner adopts the market that fits, and the platform carries the rest.